Typical TB500 Dosing Schedule Loading Phase (Weeks 14): Dosage: 48 mg per week Frequency: Split into 2 injections per week (e.g., Monday/Thursday) Goal: Rapid saturation of soft tissue to initiate repair Maintenance Phase (Weeks 58 or longer): Dosage: 26 mg per month Frequency: 1 injection every 714 days Goal: Support long-term recovery and tissue integrity Users typically adjust their dose based on: Injury severity Body weight Co-administration with BPC157 or other peptides Note: These guidelines are based on research chemical protocols and anecdotal data
GLP-1 agonists (semaglutide, tirzepatide) reduce appetite and slow gastric emptying to create caloric deficits, while AOD-9604 and 5-Amino-1MQ directly enhance fat mobilisation and oxidation without affecting satiety signalling
Can I run it alongside semaglutide or tirzepatide?+ There is no interaction study, so nobody can give you a data-backed answer
For a deeper comparison, see Peptide Mind's bacteriostatic water guide
A 2024 mouse study measured 3.5% oral bioavailability
This guide is narrower: where to put BPC-157, whether it matters that you inject near an injury, and how to do it cleanly